Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Development, 141(23), 4432-4447
10.1007/s40257-020-00565-5 130 ZengX.XieY
CJC-1295 Best for: Sustained growth-hormone-axis stimulation for lean mass and recovery support CJC-1295 is a synthetic growth-hormone-releasing hormone (GHRH) analog, a modified 29-amino-acid peptide originally developed by ConjuChem Biotechnologies
Optimise protein intake: Adequate dietary protein is fundamental to muscle preservation
A 17% Reduction in Overall Cancer Risk A landmark study published in JAMA Oncology (Dai H et al., August 2025), drawing on data from 14 health systems encompassing approximately 20 million patients, found that adults with obesity who were prescribed GLP-1 receptor agonists had a 17% lower risk of developing cancer compared to carefully matched non-users
US$ 21.28
US$ 26.63
US$ 28.12
US$ 21.22
US$ 21.63
